Tums Tablet
NDC Package 0135-0521-01
Package Information
Tums (calcium carbonate) tablets is a medication used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. This formulation utilizes a tablet delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0135-0521 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 1044532 - Tums Extra Strength 750 MG (Ca 300 MG) Chewable Tablet
- RxCUI: 1044532 - calcium carbonate 750 MG Chewable Tablet [Tums]
- RxCUI: 1044532 - Tums Chewy Bites 750 MG Chewable Tablet
- RxCUI: 1044532 - Tums E-X 750 MG (calcium 300 MG) Chewable Tablet
- RxCUI: 1044532 - Tums Kids 750 MG Chewable Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0135 - Haleon Us Holdings Llc
- 0135-0521 - Tums
- 0135-0521-01 - 8 TABLET in 1 PACKAGE
- 0135-0521 - Tums
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0135-0521). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0135-0521-01 identifies a specific commercial package of 8 tablet in 1 package of Tums EX, a human over the counter drug labeled by Haleon Us Holdings Llc. This tablet is formulated for oral use and contains calcium carbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on March 23, 2011. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00135052101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.